Followers | 0 |
Posts | 2177 |
Boards Moderated | 0 |
Alias Born | 04/13/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 05, 2022 9:26:17 AM
But even at 28 days where there was no more leronlimab in the system , mortality benefit was 31% ABOVE all SOC drugs..
Again, CYDY's own trial report stated that at Day 28 the survival rate for the drug group was 31%.
MOST IMPORTANTLY CYDY NEVER DID A COMPETITIVE DRUG TRIAL COMPARING LERONLIMAB AGAINST ANY OTHER DRUG. SO IT IS IMPOSSIBLE FOR IT TO EVER CLAIM IT HAS A "31% BENEFIT ABOVE ALL OTHER DRUGS."
Now The Big Contradiction:
Yes here we are in the critical patients , leronlimab without one serious side effect , with 82% mortality benefits above ALL THESE TOXIC SOC drugs with very minimal efficacy.
HOW CAN IT BE 31% AND 82% ABOVE ALL SOC DRUGS AT THE SAME TIME?!?!
The answer is it can't and the only way to for it to happen is by a deliberate misinterpreting of the data or flat out lying. Which is exactly what Nader did and why the SEC, DOJ, and FDA came down on him en masse.
Even with sabotaged by FDA study , with only 2 injections of leronlimab at 0 and 7 days, results are very clear.
Again, CYDY designed the trial. The trial was designed, presented to Nader and he signed off on it. The FDA didn't tell CYDY how to do it's trials. The FDA did tell CYDY it lacked statistical significance, it couldn't change trial designs mid trial, and that none of Nader's claims were true.
At 7 days there was 78% mortality benefit ABOVE ALL SOC drugs ...
At 14 days , it was 82% ,
82 % mortality benefit , how much smaller the death number will be.
That wasn't the study. The study had results at 28 days. At day 28 that survival rate fell to 31%. Nothing dramatically saving lives that would trigger an EUA. Especially when statistical significance could not be achieved, which every other drug has managed to do.
There is a reason for almost 1 M Americans death in the last 2 years , and most of people died in the last 1 year , the more SOC drugs are use , the more are dying...
We know for a fact that the majority of deaths are occurring in state's with low vaccination rates. Right now Alabama has the highest rise in COVID cases.
What is keeping the vaccination rates low? MISINFORMATION
This is why debunking stuff like this is important. Misinformation kills.
Recent CYDY News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2024 09:21:30 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/22/2024 01:00:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:17:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/09/2024 09:16:28 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/09/2024 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 12:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
FEATURED ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM